Pacific Edge Q4 Test Volumes Rise with Medicare Policy Momentum and New Commercial Coverage

• Q4 2026 test volumes increased 2.7% to 5,582 tests despite sales force reductions and winter storms
• Novitas expert panel strongly supported Cxbladder tests, with draft Medicare coverage policy expected by Q2 2027
• Major US commercial payers Blue Cross Blue Shield North Carolina, South Carolina, and Highmark adopted coverage for Cxbladder tests
• Singapore General Hospital and Townsville University Hospital integrated Cxbladder tests into clinical pathways